gene therapy - Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clini
goal is to reduce the amount of l-dopa you need to take
Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC 1 in Advanced Parkinson's Disease - MarketWatch |
All times are GMT -5. The time now is 12:12 PM. |
Powered by vBulletin Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
vBulletin Optimisation provided by
vB Optimise v2.7.1 (Lite) -
vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.